Technology Update: Measuring the Blood's Clotting Ability With ClotChip

View as a webpage

Big Advances for ClotChip Technology

  • XaTek Inc., a Cleveland-based company developing a portable sensing system that can quickly assess the clotting ability of a person’s blood, recently raised $9.1 million in Series A capital to further advance and test the device, called ClotChip.
  • A 200-person clinical trial conducted at Louis Stokes Cleveland VA Medical Center ended in July. This fall, a ClotChip trial involving hemophiliacs will be conducted at University Hospitals Rainbow Babies and Children's Hospital.
  • Publication of a research paper on the ClotChip in the Journal of Thrombosis and Hemostasis, titled Assessment of Whole Blood Coagulation with a Microfluidic Dielectric Sensor, can be viewed through Wiley Online Library.
  • US Patent No. 9,995,701, titled Capacitive Sensing Apparatuses, Systems and Methods of Making Same, issued on June 12, 2018. Inventors: Pedram Mohseni, Michael Suster, Mehran Bakshiani, and Umut Gurkan.

The team of researchers involved in the development, testing, and clinical trials of ClotChip include the following APT Center Investigators:

Full length original stories can be found at Crain's Cleveland Business,, the Daily on July 11th, and the Daily on July 20th.


Have something to share? Send YOUR good news and professional accomplishments to
Rebecca Polito at